Anna Helgadottir

Anna Helgadottir

Auto-generated profile, based on publicly available information

Anna Helgadottir

DeCODE Genetics, Reykjavik, Iceland

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SSSonia Shah
Sonia Shah
AHAlbert Henry
Albert Henry
CRCarolina Roselli
Carolina Roselli
HLHonghuang Lin
Honghuang Lin
GSGarðar Sveinbjörnsson
Garðar Sveinbjörnsson
RLR. Thomas Lumbers
R. Thomas Lumbers
Heart failure (HF) is a leading cause of morbidity and mortality worldwide. A small proportion of HF cases are attributable to monogenic cardiomyopathies and existing genome-wide association studies (GWAS) have yielded only limited insights, leaving the observed heritability of HF largely unexplained. We report results from a GWAS meta-analysis of HF comprising 47,309 cases and 930,014 controls. Twelve independent variants at 11 genomic loci are associated with HF, all of which demonstrate one or more associations with coronary artery disease (CAD), atrial fibrillation, or reduced left ventricular function, suggesting shared genetic aetiology. Functional analysis of non-CAD-associated loci implicate genes involved in cardiac development (MYOZ1, SYNPO2L), protein homoeostasis (BAG3), and cellular senescence (CDKN1A). Mendelian randomisation analysis supports causal roles for several HF risk factors, and demonstrates CAD-independent effects for atrial fibrillation, body mass index, and hypertension. These findings extend our knowledge of the pathways underlying HF and may inform new therapeutic strategies.

6 December 2022 in Nature Genetics
Verified
Journal Article
Open access
PDF file
KAKrishna G. Aragam
Krishna G. Aragam
TJTao Jiang
Tao Jiang
AGAnuj Goel
Anuj Goel
Stavroula KanoniStavroula Kanoni
Stavroula Kanoni
BWBrooke N. Wolford
Brooke N. Wolford
ECEpic- Cvd
Epic- Cvd
The discovery of genetic loci associated with complex diseases has outpaced the elucidation of mechanisms of disease pathogenesis. Here we conducted a genome-wide association study (GWAS) for coronary artery disease (CAD) comprising 181,522 cases among 1,165,690 participants of predominantly European ancestry. We detected 241 associations, including 30 new loci. Cross-ancestry meta-analysis with a Japanese GWAS yielded 38 additional new loci. We prioritized likely causal variants using functionally informed fine-mapping, yielding 42 associations with less than five variants in the 95% credible set. Similarity-based clustering suggested roles for early developmental processes, cell cycle signaling and vascular cell migration and proliferation in the pathogenesis of CAD. We prioritized 220 candidate causal genes, combining eight complementary approaches, including 123 supported by three or more approaches. Using CRISPR–Cas9, we experimentally validated the effect of an enhancer in MYO9B, which appears to mediate CAD risk by regulating vascular cell motility. Our analysis identifies and systematically characterizes >250 risk loci for CAD to inform experimental interrogation of putative causal mechanisms for CAD.

24 October 2022 in Nature Genetics
Verified
Journal Article
Open access
PDF file
GSGardar Sveinbjornsson
Gardar Sveinbjornsson
MUMagnus O. Ulfarsson
Magnus O. Ulfarsson
RTRosa B. Thorolfsdottir
Rosa B. Thorolfsdottir
BJBenedikt A. Jonsson
Benedikt A. Jonsson
EEEythor Einarsson
Eythor Einarsson
KSKari Stefansson
Kari Stefansson
Nonalcoholic fatty liver (NAFL) and its sequelae are growing health problems. We performed a genome-wide association study of NAFL, cirrhosis and hepatocellular carcinoma, and integrated the findings with expression and proteomic data. For NAFL, we utilized 9,491 clinical cases and proton density fat fraction extracted from 36,116 liver magnetic resonance images. We identified 18 sequence variants associated with NAFL and 4 with cirrhosis, and found rare, protective, predicted loss-of-function variants inMTARC1andGPAM, underscoring them as potential drug targets. We leveraged messenger RNA expression, splicing and predicted coding effects to identify 16 putative causal genes, of which many are implicated in lipid metabolism. We analyzed levels of 4,907 plasma proteins in 35,559 Icelanders and 1,459 proteins in 47,151 UK Biobank participants, identifying multiple proteins involved in disease pathogenesis. We show that proteomics can discriminate between NAFL and cirrhosis. The present study provides insights into the development of noninvasive evaluation of NAFL and new therapeutic options.

25 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
VSValgerdur Steinthorsdottir
Valgerdur Steinthorsdottir
RMRalph McGinnis
Ralph McGinnis
NWNicholas O. Williams
Nicholas O. Williams
LSLilja Stefansdottir
Lilja Stefansdottir
GTGudmar Thorleifsson
Gudmar Thorleifsson
KSKari Stefansson
Kari Stefansson
Preeclampsia is a serious complication of pregnancy, affecting both maternal and fetal health. In genome-wide association meta-analysis of European and Central Asian mothers, we identify sequence variants that associate with preeclampsia in the maternal genome atZNF831/20q13 andFTO/16q12. These are previously established variants for blood pressure (BP) and theFTOvariant has also been associated with body mass index (BMI). Further analysis of BP variants establishes that variants atMECOM/3q26,FGF5/4q21 andSH2B3/12q24 also associate with preeclampsia through the maternal genome. We further show that a polygenic risk score for hypertension associates with preeclampsia. However, comparison with gestational hypertension indicates that additional factors modify the risk of preeclampsia.

1 August 2012 in JACC
Verified
Journal Article
Closed access
AHAnna Helgadottir
Anna Helgadottir
SGSolveig Gretarsdottir
Solveig Gretarsdottir
GTGudmar Thorleifsson
Gudmar Thorleifsson
HHHilma Holm
Hilma Holm
RPRiyaz S. Patel
Riyaz S. Patel
KSKari Stefansson
Kari Stefansson

22 October 2018 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
FZFlorian Zink
Florian Zink
DMDroplaug N. Magnusdottir
Droplaug N. Magnusdottir
OMOlafur T. Magnusson
Olafur T. Magnusson
NWNicolas J. Walker
Nicolas J. Walker
TMTiffany J. Morris
Tiffany J. Morris
KSKari Stefansson
Kari Stefansson